rs201061621
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM1PP2
The NM_000053.4(ATP7B):c.2921C>T(p.Thr974Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000371 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. T974T) has been classified as Likely benign.
Frequency
Consequence
NM_000053.4 missense
Scores
Clinical Significance
Conservation
Publications
- Wilson diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ATP7B | NM_000053.4 | c.2921C>T | p.Thr974Met | missense_variant | Exon 13 of 21 | ENST00000242839.10 | NP_000044.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000276 AC: 42AN: 152246Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000144 AC: 36AN: 249450 AF XY: 0.000140 show subpopulations
GnomAD4 exome AF: 0.000381 AC: 557AN: 1461846Hom.: 0 Cov.: 32 AF XY: 0.000363 AC XY: 264AN XY: 727222 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000276 AC: 42AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.000229 AC XY: 17AN XY: 74384 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Wilson disease Uncertain:8Other:1
- -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
- -
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 974 of the ATP7B protein (p.Thr974Met). This variant is present in population databases (rs201061621, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with ATP7B-related conditions. ClinVar contains an entry for this variant (Variation ID: 289465). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This missense variant replaces threonine with methionine at codon 974 of the ATP7B protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with Wilson disease (PMID: 18373411, 27935710, 30097039). In one of these individuals, this variant was reported in the compound heterozygous state (PMID: 27935710). This variant has been identified in 46/280856 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
- -
The ATP7B c.2921C>T; p.Thr974Met variant (rs201061621) has been described in an individual with a clinical diagnosis of Wilson disease (Davies 2008). The variant is reported in the ClinVar (Variation ID: 289465) and is listed in the general population with an overall allele frequency of 0.016% (46/280856 alleles) in the Genome Aggregation Database. The threonine at codon 974 is moderately conserved, occurs in the ATPase domain, and computational analyses predict that this variant is deleterious (REVEL: 0.746). Additionally, other variants in threonines in this region (p.Thr935Met, p.Thr977Met) are considered pathogenic. However, given the lack of clinical and functional data, the significance of the p.Thr974Met variant is uncertain at this time. References: Davies LP et al. New mutations in the Wilson disease gene, ATP7B: implications for molecular testing. Genet Test. 2008 Mar;12(1):139-45. PMID: 18373411. -
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
not provided Uncertain:4
- -
PP3 -
- -
Reported previously in an individual with a reported diagnosis of Wilson disease; however, further phenotypic information was not provided, and it is unclear whether or not this individual also harbored a second ATP7B variant (PMID: 18373411); Reported in an individual with alcoholic liver cirrhosis whose biochemistry did not support a diagnosis of Wilson disease (PMID: 27935710); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 22692182, 18373411, 30097039, 34426522, 37937776, 27935710) -
not specified Uncertain:1
Variant summary: AATP7B c.2921C>T (p.Thr974Met) results in a non-conservative amino acid change located in the transmembrane 6 region, could affect protein conformation, as other variants (DVs) in this domain have been shown to do, or disrupt the transport of copper across the lipid bilayer. However, there are currently no studies to support such predictions. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00014 in 249500 control chromosomes (gnomAD and publication data). This frequency is not significantly higher than estimated for a pathogenic variant in ATP7B causing Wilson Disease (0.00014 vs 0.0054), allowing no conclusion about variant significance. c.2921C>T has been reported in the literature in individuals affected with Wilson Disease (examples: Davies_2008, Jung_2017). These data do not allow any conclusion about variant significance. The following publications have been ascertained in the context of this evaluation (PMID: 30097039, 18373411, 27935710, 23235335, 20465995, 31449670, 22692182, 31059521, 24253677, 31751128). ClinVar contains an entry for this variant (Variation ID: 289465). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Inborn genetic diseases Uncertain:1
Identified in one patient with Wilson disease; however, no second ATP7B variant was reported (Davies, 2008)_x000D_ _x000D_ Studies of evolutionary conservation and structure were inconclusive regarding the effect of this alteration on protein function (Schushan, 2012) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at